Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
$-22.48 Mil
% of Total Estimate Gain
-90.43%

HIGHLINE CAPITAL MANAGEMENT, L.P.'s Passage Bio Inc Holding Summary

As of 2022-12-31, HIGHLINE CAPITAL MANAGEMENT, L.P. held - shares of Passage Bio Inc(PASG), totaling N/A. This investment constitutes 0% of their stock portfolio, and HIGHLINE CAPITAL MANAGEMENT, L.P. now holds 0% of the outstanding Passage Bio Inc(PASG) stock.

The initial trade took place in 2020Q2. And since then HIGHLINE CAPITAL MANAGEMENT, L.P. has made 6 purchases of PASG, at an average price of $19.37, for a total of 1.28 Mil shares. In addition, there have been 2 sales at an average price of $1.85 for 1.28 Mil shares. Based on historical transaction data and PASG's current price of $0.38, HIGHLINE CAPITAL MANAGEMENT, L.P.'s estimated gain on his PASG holdings is $-22.48 Mil, reflecting a -90.43% gain to date.

HIGHLINE CAPITAL MANAGEMENT, L.P. PASG ($0.38) Holding Chart

HIGHLINE CAPITAL MANAGEMENT, L.P. PASG ($0.38) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1